Besides, they treated tendon-derived fibroblasts with IL-17 cytokines and confirmed that they induced a direct response and activated diverse pro-inflammatory signaling pathways, which indicated the IL-17 acted as amplifiers of tendon inflammation and should be target as potential therapeutic role in tendinopathy. Here, IL17A is linked to disease of the tendon.